IL135538A - Halogen substituted tetracyclic tetrahydrofuran derivatives - Google Patents

Halogen substituted tetracyclic tetrahydrofuran derivatives

Info

Publication number
IL135538A
IL135538A IL13553898A IL13553898A IL135538A IL 135538 A IL135538 A IL 135538A IL 13553898 A IL13553898 A IL 13553898A IL 13553898 A IL13553898 A IL 13553898A IL 135538 A IL135538 A IL 135538A
Authority
IL
Israel
Prior art keywords
halogen substituted
tetrahydrofuran derivatives
substituted tetracyclic
tetracyclic tetrahydrofuran
derivatives
Prior art date
Application number
IL13553898A
Other languages
English (en)
Other versions
IL135538A0 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL135538A0 publication Critical patent/IL135538A0/xx
Publication of IL135538A publication Critical patent/IL135538A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13553898A 1997-10-10 1998-10-06 Halogen substituted tetracyclic tetrahydrofuran derivatives IL135538A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203154 1997-10-10
PCT/EP1998/006352 WO1999019317A1 (en) 1997-10-10 1998-10-06 Halogen substituted tetracyclic tetrahydrofuran derivatives

Publications (2)

Publication Number Publication Date
IL135538A0 IL135538A0 (en) 2001-05-20
IL135538A true IL135538A (en) 2005-07-25

Family

ID=8228817

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13553898A IL135538A (en) 1997-10-10 1998-10-06 Halogen substituted tetracyclic tetrahydrofuran derivatives

Country Status (36)

Country Link
US (2) US6511976B1 (xx)
EP (1) EP1021432B1 (xx)
JP (1) JP3248902B2 (xx)
KR (1) KR100366014B1 (xx)
CN (1) CN100340554C (xx)
AP (1) AP1239A (xx)
AR (1) AR017325A1 (xx)
AT (1) ATE235479T1 (xx)
AU (1) AU737334B2 (xx)
BG (1) BG64387B1 (xx)
BR (1) BR9812871A (xx)
CA (1) CA2305612C (xx)
CZ (1) CZ296928B6 (xx)
DE (1) DE69812668T2 (xx)
DK (1) DK1021432T3 (xx)
EA (1) EA003698B1 (xx)
EE (1) EE04526B1 (xx)
ES (1) ES2195403T3 (xx)
HK (1) HK1029106A1 (xx)
HR (1) HRP20000189A2 (xx)
HU (1) HU225161B1 (xx)
ID (1) ID23903A (xx)
IL (1) IL135538A (xx)
MY (1) MY117783A (xx)
NO (1) NO317159B1 (xx)
NZ (1) NZ503294A (xx)
OA (1) OA11898A (xx)
PL (1) PL339833A1 (xx)
PT (1) PT1021432E (xx)
SI (1) SI1021432T1 (xx)
SK (1) SK284028B6 (xx)
TR (1) TR200000918T2 (xx)
TW (1) TW567186B (xx)
UA (1) UA52778C2 (xx)
WO (1) WO1999019317A1 (xx)
ZA (1) ZA989204B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA79248C2 (en) 2001-11-09 2007-06-11 Janssen Pharmaceutica Nv Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
BR0214068A (pt) * 2001-12-07 2004-10-13 Janssen Pharmaceutica Nv Preparação de derivados 3,3a,8,12b-tetrahidro-2h-dibenzo [3,4:6,7]ciclohepta[1,2-b] furano transfundidos
IL162350A0 (en) * 2001-12-07 2005-11-20 Janssen Pharmaceutica Nv Preparation of cis-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6.7ÜcycloheptaÄ1,2-bÜfuran derivatives
HRP20020305A8 (en) 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020441A2 (en) * 2002-05-21 2003-12-31 Pliva D D 1-oxa-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20030160A2 (en) * 2003-03-06 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. 1-thiadibenzoazulene derivatives and biological action thereof
HRP20030885A2 (en) * 2003-11-03 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS
HRP20030954A2 (en) * 2003-11-21 2005-08-31 Pliva D.D. USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030955A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030957A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1-THIA-3-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030958A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1,3-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030956A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANU
HRP20030959A2 (xx) * 2003-11-21 2005-10-31 Pliva-Istra�iva�ki institut d.o.o.
HRP20030953A2 (en) * 2003-11-21 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. PREPARATION OF 1-AZA-2-OXA-DIBENZO[e,h]AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20040104A2 (en) * 2004-01-30 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
CN1968942B (zh) * 2004-06-14 2011-06-15 詹森药业有限公司 四环四氢呋喃衍生物
CA2568752C (en) 2004-06-23 2013-05-07 Janssen Pharmaceutica N.V. Novel unsaturated tetracyclic tetrahydrofuran derivatives
AU2011202995B2 (en) * 2004-12-07 2012-02-02 Janssen Pharmaceutica N.V. Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
EP1824820A2 (en) 2004-12-07 2007-08-29 Janssen Pharmaceutica N.V. Substituted tetracyclic tetrahydrofuran,pyrrolidine and tetrahydrothiophene derivatives
ES2391780T3 (es) 2005-01-27 2012-11-29 Janssen Pharmaceutica Nv Derivados de tetrahidrofurano tetracíclicos como inhibidores de 5HT2 en el tratamiento de trastornos de SNC
KR20080015407A (ko) * 2005-05-19 2008-02-19 얀센 파마슈티카 엔.브이. 사이클릭 아민 측쇄를 함유한 선택된 테트라사이클릭테트라하이드로푸란 유도체
BRPI0611408A2 (pt) * 2005-05-26 2010-09-08 Janssen Pharmaceutica Nv derivados de tetra-hidrofurano tetracìclico substituìdo, pirrolidina e tetrahidrotiofeno, seus usos como um medicamento, composição farmacêutica e processo para o preparo da mesma
NZ564181A (en) * 2005-06-17 2010-02-26 Janssen Pharmaceutica Nv Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
US9125866B1 (en) 2015-01-28 2015-09-08 King Saud University Antidepressant compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552399A (en) * 1994-11-02 1996-09-03 Janssen Pharmaceutica N.V. Substituted tetracyclic azepine derivatives
ATE199088T1 (de) * 1994-11-02 2001-02-15 Janssen Pharmaceutica Nv Substituierte tetracyclische oxazepine- und thiazepinederivate mit 5-ht2 rezeptoraffinität
EE03612B1 (et) * 1996-04-12 2002-02-15 Janssen Pharmaceutica N.V. Asendatud tetratsüklilised tetrahüdrofuraanderivaadid
DE69725459T2 (de) 1996-08-28 2004-08-12 Eli Lilly And Co., Indianapolis Substituierte 1,2,3,4-tetrahydro-2-dibenzofuranamine und 2-aminocyclohepta(b)benzofurane

Also Published As

Publication number Publication date
EP1021432A1 (en) 2000-07-26
AP1239A (en) 2004-01-15
US20030134852A1 (en) 2003-07-17
AR017325A1 (es) 2001-09-05
ID23903A (id) 2000-05-25
TR200000918T2 (tr) 2000-07-21
EE200000161A (et) 2001-04-16
MY117783A (en) 2004-08-30
IL135538A0 (en) 2001-05-20
NO20001792L (no) 2000-04-06
PL339833A1 (en) 2001-01-02
WO1999019317A1 (en) 1999-04-22
CA2305612C (en) 2007-07-31
AU9629698A (en) 1999-05-03
CN1274353A (zh) 2000-11-22
UA52778C2 (uk) 2003-01-15
KR100366014B1 (ko) 2002-12-26
OA11898A (en) 2006-04-10
HUP0003748A2 (hu) 2002-01-28
HU225161B1 (en) 2006-07-28
DE69812668T2 (de) 2004-01-29
HUP0003748A3 (en) 2002-02-28
SK284028B6 (sk) 2004-08-03
DK1021432T3 (da) 2003-07-14
SI1021432T1 (en) 2003-08-31
BR9812871A (pt) 2000-08-08
NO317159B1 (no) 2004-08-30
JP3248902B2 (ja) 2002-01-21
TW567186B (en) 2003-12-21
CN100340554C (zh) 2007-10-03
KR20010023292A (ko) 2001-03-26
BG64387B1 (bg) 2004-12-30
EA200000400A1 (ru) 2000-10-30
CA2305612A1 (en) 1999-04-22
AU737334B2 (en) 2001-08-16
BG104287A (en) 2000-11-30
NZ503294A (en) 2001-08-31
ATE235479T1 (de) 2003-04-15
DE69812668D1 (de) 2003-04-30
AP2000001784A0 (en) 2000-06-30
ES2195403T3 (es) 2003-12-01
EP1021432B1 (en) 2003-03-26
EA003698B1 (ru) 2003-08-28
HRP20000189A2 (en) 2001-02-28
US6699858B2 (en) 2004-03-02
JP2001519425A (ja) 2001-10-23
CZ296928B6 (cs) 2006-07-12
ZA989204B (en) 2000-04-10
US6511976B1 (en) 2003-01-28
EE04526B1 (et) 2005-08-15
CZ20001136A3 (cs) 2000-08-16
HK1029106A1 (en) 2001-03-23
NO20001792D0 (no) 2000-04-06
PT1021432E (pt) 2003-08-29
SK4712000A3 (en) 2000-10-09

Similar Documents

Publication Publication Date Title
IL135538A0 (en) Halogen substituted tetracyclic tetrahydrofuran derivatives
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
EG24081A (en) 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
IL126951A0 (en) Carboline derivatives
HUP0003642A3 (en) N-alkanoylphenylalanine derivatives
GB9702194D0 (en) Sulphonide derivatives
ZA987602B (en) N-alkanoylphenylalanine derivatives
ZA975543B (en) Phenylamino-substituted tricyclic derivatives
GB9718913D0 (en) Substituted oxindole derivatives
HU9801168D0 (en) Triazinylaminostilbene derivatives
ZA987813B (en) Substituted chroman derivatives
ZA984560B (en) Ergoline derivatives
IL135074A0 (en) Substituted chroman derivatives
IL132982A0 (en) Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
GB9715821D0 (en) Amidino-camptothecin derivatives
GB2321457B (en) 5-Aroylnaphthalene derivatives
ZA959215B (en) Substituted tetracyclic azepine derivatives
GB9725541D0 (en) Amino-benzothiazole derivatives
GB9701628D0 (en) Imino-aza-anthracyclinone derivatives
ZA983116B (en) Arylsecocholadiene derivatives
HU9800889D0 (en) New naphtylpiperazine derivatives
IL131159A0 (en) 4-Aminoethoxyindazole derivatives
GB9706753D0 (en) Aralkoxy-morphinan derivatives
SI1005445T1 (en) N-alkanoylphenylalanine derivatives
GB9612138D0 (en) Substituted carboxylated derivatives

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees